The market is projected to grow from $63.7 billion in 2023 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period. The biomarker market is ...

This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of upstream processing.

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...